Kerst J M, Van Coevorden F, Peterse J, Haas R L M, Linn S C
Antoni van Leeuwenhoek Ziekenhuis, afd. Medisch-Oncologische Disciplines, Plesmanlaan 121, 1066 CX Amsterdam.
Ned Tijdschr Geneeskd. 2004 Jul 3;148(27):1355-8.
Ewing's sarcoma was diagnosed in three men, one aged 22 and two aged 30. The disease was diagnosed by biopsy and chromosome investigations (t(11;22)-translocation). In the youngest patient with localised disease, supplementary radiotherapy was withheld in view of the good results of induction chemotherapy, surgery and consolidation chemotherapy. However, four months later, there was a localised recurrence, again followed by induction chemotherapy, chemotherapy at high dosage, stem cell transplantation, radiotherapy and finally surgical intervention, after which a complete remission was achieved. The 30-year-old man with localised disease was given induction chemotherapy, surgery, consolidation chemotherapy and radiotherapy; 14 months after the diagnosis he was in good condition. The other 30-year-old man had metastases in TXII and both lungs. Despite intensive therapy he died 8 months after diagnosis. Ewing's sarcoma is a musculoskeletal malignancy that occurs in children and adolescents but also in young adults. It generally manifests itself as a painful swelling originating in bone or soft tissue. There are often accompanying symptoms such as weight loss and fever. In 20-25% of cases there are already metastases (to the lungs, bone and bone marrow) by the time of diagnosis. The diagnosis and treatment of this rare, therapy-sensitive disease should take place in a study setting and in co-operation with a multidisciplinary sarcoma working group.
三名男性被诊断出患有尤因肉瘤,一名22岁,两名30岁。该病通过活检和染色体检查(t(11;22)易位)确诊。在最年轻的患有局限性疾病的患者中,鉴于诱导化疗、手术和巩固化疗效果良好,未进行辅助放疗。然而,四个月后出现局部复发,再次进行诱导化疗、高剂量化疗、干细胞移植、放疗,最后进行手术干预,之后实现了完全缓解。患有局限性疾病的30岁男性接受了诱导化疗、手术、巩固化疗和放疗;诊断后14个月,他状况良好。另一名30岁男性在T12和双肺有转移。尽管进行了强化治疗,他在诊断后8个月死亡。尤因肉瘤是一种发生于儿童、青少年及年轻成人的肌肉骨骼恶性肿瘤。它通常表现为起源于骨骼或软组织的疼痛性肿胀。常伴有体重减轻和发热等症状。在20%至25%的病例中,诊断时已有转移(至肺、骨和骨髓)。这种罕见的、对治疗敏感的疾病的诊断和治疗应在研究环境中并与多学科肉瘤工作组合作进行。